Cholestech (CTEC) Partners with Onsite Health Diagnostics for On-site, Corporate Health Screenings
Cholestech Corporation (Nasdaq: CTEC) has teamed up with Onsite Health Diagnostics, one of the largest providers of comprehensive, on-site, corporate health screenings. The agreement, valued at an estimated $3 million dollars over the next three years, establishes Cholestech LDX testing system as the preferred device for Onsite screeners to monitor for risk factors associated with stroke, heart disease, diabetes and inflammatory disorders.
You May Also Be Interested In
- DISH Network (DISH) Sued by Networks for 'Commercial Skipping' Feature
- Pfizer (PFE) Axitinib Gets Positive Opinion from CHMP EMA
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
